Literature DB >> 10343628

Demonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum.

L Greiff1, M Andersson, C Svensson, M Linden, P Wollmer, C G Persson.   

Abstract

BACKGROUND: Patients with seasonal allergic rhinitis may develop bronchial hyperresponsiveness during the active disease period. Eosinophil activation may occur in the bronchial mucosa and may be reflected by increased sputum levels of eosinophil cationic protein (ECP), especially when ECP binding proteins such as alpha 2-macroglobulin pass through the lamina propria and across the epithelium into the airway lumen. A study was therefore undertaken to determine histamine airway responsiveness (FEV1) and bronchovascular responsiveness (exudation of alpha 2-macroglobulin) to histamine in subjects with seasonal allergic rhinitis, and to explore whether sputum ECP levels are increased by the use of induced exudation followed by induced sputum.
METHODS: Eleven patients with seasonal allergic rhinitis were examined before and during a birch pollen season. Sputum was induced by inhalation of 4.5% saline twice before and twice during the pollen season. Histamine inhalations were given before the second of each pair of sputum inductions at increasing concentrations until FEV1 was reduced by 20%. Sputum levels of alpha 2-macroglobulin and ECP were determined as indices of bronchial exudation of plasma and activation of bronchial eosinophils, respectively.
RESULTS: Bronchomotor responsiveness increased during the pollen season (median difference in the reduction of FEV1 9% (95% confidence interval (CI) -3 to 26)) but histamine induced exudation of plasma was not increased. Baseline sputum levels of alpha 2-macroglobulin and ECP did not increase. Histamine induced exudation of alpha 2-macroglobulin was associated with increased sputum levels of ECP exclusively during the pollen season (median difference 8.2 ng/ml (95% CI 0.4 to 562.0)).
CONCLUSION: Bronchial hyperresponsiveness in seasonal allergic rhinitis may not be associated with bronchovascular exudative hyperresponsiveness. Sputum levels of ECP were increased only during the season, and only after induced exudation (potentially moving ECP to the mucosal surface). It is suggested that the combined method of induced exudation and induced sputum may significantly improve the yield of some markers of inflammation in sputum samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343628      PMCID: PMC1745349          DOI: 10.1136/thx.54.1.33

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

1.  The use of the nose to study the inflammatory response of the respiratory tract.

Authors:  C G Persson; C Svensson; L Greiff; M Anderson; P Wollmer; U Alkner; I Erjefält
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

Review 2.  Extravasation, lamina propria flooding and lumenal entry of bulk plasma exudate in mucosal defence, inflammation and repair.

Authors:  C G Persson; J S Erjefält; M Andersson; L Greiff; C Svensson
Journal:  Pulm Pharmacol       Date:  1996-06

3.  Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.

Authors:  C G Peterson; P Venge
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

Review 4.  Interactions between cytokines and alpha 2-macroglobulin.

Authors:  K James
Journal:  Immunol Today       Date:  1990-05

5.  Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis.

Authors:  M Aubier; J Levy; C Clerici; F Neukirch; D Herman
Journal:  Am Rev Respir Dis       Date:  1992-07

6.  Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood.

Authors:  E Pizzichini; M M Pizzichini; A Efthimiadis; J Dolovich; F E Hargreave
Journal:  J Allergy Clin Immunol       Date:  1997-04       Impact factor: 10.793

7.  The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.

Authors:  S Rak; O Löwhagen; P Venge
Journal:  J Allergy Clin Immunol       Date:  1988-09       Impact factor: 10.793

Review 8.  The eosinophil and the pathophysiology of asthma.

Authors:  E Frigas; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1986-04       Impact factor: 10.793

9.  Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma.

Authors:  J M Henriksen; A Wenzel
Journal:  Am Rev Respir Dis       Date:  1984-12

10.  Asthma and allergic rhinitis in the same patients.

Authors:  P A Pedersen; E R Weeke
Journal:  Allergy       Date:  1983-01       Impact factor: 13.146

View more
  2 in total

Review 1.  [Asthma, allergic rhinitis, sinusitis. Concept of the "unified respiratory tracts"].

Authors:  J C Virchow
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

Review 2.  Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma.

Authors:  Carl Persson
Journal:  J Allergy Clin Immunol       Date:  2018-08-29       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.